Member Info for technick

There are two aspects to the Indian market in terms of testing, the public market (where the government are placing pricing requirements) and the private market such as DIVOC where there is room to charge more for a better test. I think GDR are smart in placing their product in the private markets first. Scale can bring the pricing down for public use, but it's a different ball game.

Sales in India now a certainty, look at DIVOCs testing numbers already, this can now be ramped up significantly....

My understanding is that all the POC molecular platforms are delayed due to added requirements being put on them... I'm happy to buy the dip that's coming our way, it won't be long as we are now Q2 so expect POC shortly!

The report was as expected, the only thing that wasn't expected is that the Company made a profit.

Lot's will get caught out in the coming weeks. The share price may well drop today based on the no significant covid sales, but this will change rapidly and those who buy the lows will do very well. I've held since 2016, this is the first time the business has made a profit, I continue to trade the rises and falls, this will soon create significant profits

Looks like Friday could be an explosive day here with updates and the company presentation

another variant suspected of overcoming the current vaccines, only a matter of time... test, test, test

https://www.independent.co.uk/news/health/covid-uk-news-live-vaccine-test-cases-b1818275.html

Trevor Brown is just a smart person. He takes options rather than salary keeping investment to a minimum. His main trading happens when he has to keep a watch on what overall percentage he owns. I have investments here and in BRH and I've done incredibly well with both investments. I bought more here taking advantage of the dips. You can not blame TB for day traders creating peaks and troughs, just do your research, look at the market opportunity, and invest if you see potential. Don;t try and ride a bandwagon, if you see it you're already too late.

I've noticed over recent weeks the company has been getting better with almost weekly news flow, I think this will help the support levels along the way to the main sales event... £93m market cap could quickly become £200m when first US and India sales are announced... not long, actually could be next week since Beckman have now started their sales process

250 2,000 SING 10:04
250 2,500 WINS 09:48
252 2,500 JBER 09:15
252 2,500 SCAP 09:25
253 2,000 PEEL 10:00
255 2,000 FCAP 08:45
270 2,500 MREX 07:50

oops, sorry that's next week :)

I saw a DIVOC health post about a 15th March announcement for testing capabilities, the post now not there... 2+2=3054?

... RNS tomorrow? Indian approvals?

they could supply POC covid tests direct to DOD who are already using the Genedrive platform, this is great!

Further indications that the business is now a products company with many avenues for sales now across different areas of medical and non-medical markets.

Dodge, more news in the no news until the 26th period :D

yes more sales coming, the business is turning into a multifaceted diagnostics company!

Just time now, Beckman completed an extensive evaluation of the GDR test on their platform, the result of which was a distribution agreement to sell the product to run on their platform. It is now just time to install customers and the US and EU represent the two largest markets for us... figures will soon come, I suspect an announcement on first sales shortly!

very low volume, I doubt there are many sellers apart from the larger ones who were exiting, if they are out this will rise sharply, if not MM will simply continue to sell into the demand

https://www.theguardian.com/world/2021/feb/08/oxford-covid-vaccine-10-effective-south-african-variant-study

GDR have said this is worth upwards of £35m per year in the UK alone, assuming same 60% margin would give £100m MC just for the UK, potentially only 3% off the market. Certainly this should provide a re-rate

how does this square with your message yesterday of 'no news until after the 26th'?

this is really great news!!

"unless it is regulated news" ie news that requires an RNS will be issued, they just won't comment on what's in the presentation ie there's nothing in the presentation that isn't already known, that's different to saying there will be no new news, anything material requiring an RNS will be announced...